MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.600
-0.190
-10.61%
Closed 16:00 05/26 EDT
OPEN
1.820
PREV CLOSE
1.790
HIGH
1.830
LOW
1.600
VOLUME
1.81K
TURNOVER
2.14K
52 WEEK HIGH
6.69
52 WEEK LOW
1.480
MARKET CAP
8.72M
P/E (TTM)
22.86
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 05/17 12:09
G Medical, ChemoCentryx top healthcare gainers; Denali, Immix among losers
Gainers: G Medical Innovations (NASDAQ:GMVD) +20%. ChemoCentryx (NASDAQ:CCXI) +12%. Homology Medicines (NASDAQ:FIXX) +8%. Babylon Holdings (NYSE:BBLN) +7%. XTL Biopharmaceuticals (NASDAQ:XTLB) +7%. Losers: Denali Therapeutics Inc. (NASDAQ:DNLI) -13%. Immix...
Seekingalpha · 01/13 15:02
Triple-S Management, Bio-Path leads healthcare gainers; Theravance Biopharma, Vivos Therapeutics among major losers
Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) -31%, Vivos...
Seekingalpha · 08/24/2021 15:10
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Benzinga · 08/24/2021 09:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 08/23/2021 12:12
25 Stocks Moving in Monday's Pre-Market Session
Gainers
Benzinga · 08/23/2021 11:00
58 Biggest Movers From Friday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
Benzinga · 08/23/2021 09:06
ONVO, JOBY and PXLW among mid-day movers
Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (N...
Seekingalpha · 08/20/2021 16:34
More
No Data
Learn about the latest financial forecast of XTLB. Analyze the recent business situations of Xtl Biopharmaceu through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Actual
Estimate
-0.30-0.22-0.14-0.07
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Institutional Holdings
Institutions: 5
Institutional Holdings: 473.82K
% Owned: 8.70%
Shares Outstanding: 5.45M
TypeInstitutionsShares
Increased
1
658
New
0
0
Decreased
1
1.80K
Sold Out
2
23.43K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.99%
Pharmaceuticals & Medical Research
+0.43%
Key Executives
Non-Executive Chairman
Doron Turgeman
Chief Executive Officer/Director
Shlomo Shalev
Chief Financial Officer
Itay Weinstein
Non-Executive Director
Dobroslav Melamed
Non-Executive Director
Alexander Rabinovitch
Non-Executive Director
Jonathan Schapiro
Non-Executive Independent Director
Osnat Fain
Non-Executive Independent Director
Iris Yalon
No Data
No Data
About XTLB
XTL Biopharmaceuticals Ltd is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers kinds of X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ:XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.